Camarda Financial Advisors, LLC Merck & Co., Inc. Transaction History

Camarda Financial Advisors, LLC

$231 Million
Q2 2024

A detailed history of Camarda Financial Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Camarda Financial Advisors, LLC holds 16,084 shares of MRK stock, worth $1.83 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

16,084

Previous 16,084 -0.0%

Holding current value

$1.83 Million

Previous $2.12 Million 6.17%

% of portfolio

0.86%

Previous 0.94%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$113.24 - $131.95 $21,175 - $24,674	-187 Reduced 1.15%	16,084 $2.12 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $17,832 - $19,405	-178 Reduced 1.08%	16,271 $1.77 Million
Q3 2023 Nov 15, 2023	SELL	$102.95 - $114.33 $5,456 - $6,059	-53 Reduced 0.32%	16,449 $1.69 Million
Q2 2023 Aug 17, 2023	BUY	$108.61 - $118.38 $108 - $118	1 Added 0.01%	16,502 $1.9 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $21,205 - $23,661	-206 Reduced 1.23%	16,501 $1.76 Million
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $32,003 - $41,032	366 Added 2.24%	16,707 $1.85 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $15,028 - $17,035	-180 Reduced 1.09%	16,341 $1.49 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $48,884 - $54,796	-665 Reduced 3.87%	16,521 $1.36 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $76,978 - $96,425	1,065 Added 6.61%	17,186 $1.32 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $490,076 - $538,960	-6,837 Reduced 29.78%	16,121 $1.21 Million
Q1 2021 May 05, 2021	BUY	$68.86 - $81.11 $470,795 - $554,549	6,837 Added 42.41%	22,958 $1.77 Million
Q4 2020 Jan 29, 2021	BUY	$71.77 - $79.65 $861 - $955	12 Added 0.07%	16,121 $1.32 Million
Q2 2020 Jul 24, 2020	SELL	$70.42 - $80.13 $84,504 - $96,156	-1,200 Reduced 6.93%	16,109 $1.25 Million
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $76,032 - $105,383	1,200 Added 7.45%	17,309 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $14,607 - $15,922	-192 Reduced 1.18%	16,109 $1.36 Million
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $14,107 - $16,481	-202 Reduced 1.22%	16,301 $1.37 Million
Q1 2019 Apr 25, 2019	BUY	$69.58 - $79.36 $46,896 - $53,488	674 Added 4.26%	16,503 $1.37 Million
Q4 2018 Jan 23, 2019	SELL	$65.24 - $75.71 $15,005 - $17,413	-230 Reduced 1.43%	15,829 $1.21 Million
Q3 2018 Oct 31, 2018	BUY	$57.69 - $67.84 $8,941 - $10,515	155 Added 0.97%	16,059 $1.14 Million
Q4 2017 Feb 07, 2018	SELL	$51.62 - $61.64 $28,442 - $33,963	-551 Reduced 3.35%	15,904 $895,000
Q3 2017 Nov 15, 2017	BUY	$58.67 - $63.13 $965,414 - $1.04 Million	16,455	16,455 $1.05 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camarda Financial Advisors, LLC with notifications on news.

Account

Camarda Financial Advisors, LLC Merck & Co., Inc. Transaction History